positive and negative symptoms
|
phenotype |
|
Sign or Symptom
|
18
|
5
|
0.060 |
None |
1.000 |
6 |
|
1996 |
2018 |
Crohn Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1382
|
1147
|
0.100 |
None |
1.000 |
3 |
2
|
2012 |
2016 |
Multiple Sclerosis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
1800
|
1022
|
0.100 |
None |
1.000 |
2 |
2
|
2011 |
2013 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
2 |
2
|
2019 |
2019 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Primary antiphospholipid syndrome
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
29
|
1
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Leukocyte adhesion deficiency type 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases
|
Disease or Syndrome
|
114
|
26
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Nonorganic psychosis
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
376
|
98
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Amputated structure (morphologic abnormality)
|
phenotype |
Wounds and Injuries
|
Acquired Abnormality
|
94
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Stage IV Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Stage III Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Stage IIB Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Stage IIA Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Stage 0 Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Parkinson's disease psychosis
|
disease |
|
Mental or Behavioral Dysfunction
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Respiratory Tract Diseases
|
Disease or Syndrome
|
1410
|
80
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
peak expiratory flow (procedure)
|
phenotype |
|
Laboratory Procedure
|
74
|
119
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Chronic venous insufficiency
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
25
|
3
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |